USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and malaria.2

JPY 670 Million (USD 4.2 Million1) Investment in a Critical Diagnostic Tool to Combat Leishmaniasis.

In addition, the GHIT Fund will invest in the following five screening projects for a total amount of approximately JPY 83 million (USD 0.5 million1):

1) Screening project against malaria by MMV and Daiichi Sankyo Co., Ltd.

2) Screening project against dengue and Zika by Eisai and Drugs for Neglected Diseases initiative (DNDi)

3) Screening project against Lassa fever by MMV and RIKEN

4) Screening project against Rift Valley fever by MMV and RIKEN

5) Screening project against Ebola and Marburg by MMV and RIKEN

LabNews Media LLC

labnews.ai 的主编是 Marita Vollborn 和 Vlad Georgescu。自 1994 年以来，他们一直是畅销书作家、科学作家和科学记者。更多关于他们的写作信息，请访问 X-Press Journalistenbüro (https://xpress-journalisten.com)。更多维基百科信息：关于 Marita：https://de.wikipedia.org/wiki/Marita_Vollborn 关于 Vlad：https://de.wikipedia.org/wiki/Vlad_Georgescu

查看完整简介